Culturally-Tailored Approach to Improve Medication Use in Patients With Heart Attacks
NCT00426231 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140
Last updated 2014-02-24
Summary
Our research aims to improve the use of medicines known to prevent recurrent heart attacks. In particular, we know that statin treatment is useful after heart attacks, but many patients do not use it. There are a few possible reasons for this. Patients cannot find affordable medicine. Their doctor may not prescribe the medicine after they leave the hospital. Some people may culturally mistrust using the medicine. So they may decide not to take it even if it is prescribed. We are developing a hospital based culturally attuned program to target this problem. In this program, a community health worker counsels and helps patients in accessing pharmacy assistance programs. We will test whether this program can improve appropriate statin use.
We will enroll patients who have heart attacks. We will compare patients who are counseled by the community health worker with those who get the usual care at baseline and at 6 and 12 months (participants enrolled during the early phase of the recruitment will have an additional study visit at 24 months). We will test if their "bad" cholesterol levels are controlled. We will find out how regularly they have filled their questionnaire and taken the medicine. Finally, we will test if they are getting benefit from the statin treatment. We will do this using blood tests and imaging the patients' arteries with ultrasound. We will also measure how cost-effective it is for a hospital to run the program.
It is our goal to develop a community health worker model that is culturally sensitive for people with cultural, educational or educational barriers. Statin use is known to benefit patients in theory; such a culturally competent program will improve health outcomes in practice. After we test it, a cost-effective program such as this can be implemented in other hospitals.
Conditions
- Coronary Arteriosclerosis
- Myocardial Infarction
Interventions
- BEHAVIORAL
-
Navigation by a health worker
Help provided by health worker to navigate medication access programs
- BEHAVIORAL
-
Information control
Information about medication access programs provided to the participant and their healthcare provider
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Dhananjay Vaidya, MBBS PhD MPH · Johns Hopkins University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-03-31
- Primary Completion
- 2009-12-31
- Completion
- 2009-12-31
Countries
- United States
Study Locations
More Related Trials
-
Familial Atherosclerosis Treatment Study
NCT00000512 ·Status: COMPLETED ·Phase: PHASE3
-
Dietary Intervention to Stop COronary Atherosclerosis in Computed Tomography
NCT02571803 ·Status: UNKNOWN ·Phase: NA
-
Prior Statin Use and Risk of CHF, ALO and Malignant Arrhythmia in Indonesian Post-Acute Coronary Syndrome Patients
NCT03596931 ·Status: COMPLETED
-
Pharmacogenomic Informed Statin Prescribing
NCT06568601 ·Status: RECRUITING ·Phase: NA
-
Observational Study of Approaches to Lipid-Lowering Therapy in Russian Patients With Coronary Heart Disease <<Treat to Goal>> (Study P05464)
NCT00730132 ·Status: COMPLETED
-
Inflammation and Coronary Endothelial Function
NCT02366091 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluate the Effect of Atorvastatin on Cerebrovascular Reactivity in Mild Cognitive Impairment (MCI)
NCT04765137 ·Status: RECRUITING ·Phase: PHASE2
-
Influence of Lipid Lowering on Impaired Coronary Flow
NCT05368545 ·Status: COMPLETED ·Phase: NA
-
Low-density Lipoprotein Cholesterol Reduction With State-of-the-art Therapy in Secondary Prevention and Major Cardiovascular Adverse Events: Republic of Srpska Registry
NCT05081336 ·Status: UNKNOWN
-
Fluvastatin After Heart Transplantation
NCT00421005 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of a Decision Aid About Statin Use in Patients With Type 2 Diabetes Mellitus
NCT00217061 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Evolocumab Added to Moderate-Intensity Statin Therapy on LDL-C Lowering and Cardiovascular Adverse Events in Patients With Acute Coronary Syndrome
NCT04100434 ·Status: UNKNOWN ·Phase: PHASE4
-
Statin Therapy To Limit Cognitive Dysfunction After Cardiac Surgery
NCT01186289 ·Status: WITHDRAWN ·Phase: NA
-
Mechanism and Intervention Research of Atherosclerosis
NCT05437107 ·Status: COMPLETED
-
Intensive Statin Therapy in PCI Patient With Acute Coronary Syndrome
NCT01372839 ·Status: UNKNOWN ·Phase: PHASE4
-
Statin Therapy In Atrial Refractoriness and Reperfusion Injury
NCT01780740 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Combined Lipid-lowering Therapy on Atherosclerotic Plaque Vulnerability in Patients With ACS
NCT05624658 ·Status: RECRUITING ·Phase: NA
-
Evaluation of Statin Mechanism Preventing Cardiovascular Disease by Post-hoc Analysis of Treating to New Targets Study
NCT03073863 ·Status: COMPLETED ·Phase: PHASE4
-
Intensive Lipid Lowering Treatment in Non-ST-elevation Acute Coronary Syndrome (NSTE-ACS) Patients
NCT01040936 ·Status: UNKNOWN ·Phase: PHASE4
-
Assessment of the Effects of Atorvastatin Therapy on Myocardial Deformation Characteristics, in Patients With STEMI
NCT02590653 ·Status: COMPLETED ·Phase: PHASE4
-
Atorvastatin Pre-Treatment Influences the Risk of Percutaneous Coronary Intervention Study
NCT00469326 ·Status: COMPLETED ·Phase: PHASE3
-
Influence of Intensive Lipid-lowering on FFRCT (The FLOW-PROMOTE Study)
NCT04737408 ·Status: UNKNOWN ·Phase: PHASE3
-
Role of Statin Therapy in Prevention of Anthracycline-Induced Cardiotoxicity
NCT05792293 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Intensive Statin Treatment in Chinese Coronary Artery Disease Patients Undergoing PCI
NCT01293097 ·Status: COMPLETED ·Phase: PHASE4
-
Eliminate Coronary Artery Disease
NCT02245087 ·Status: TERMINATED ·Phase: PHASE2